Eos Management L.P. Acquires 2,773 Shares of UnitedHealth Group Incorporated $UNH

Eos Management L.P. boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 57.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 7,616 shares of the healthcare conglomerate’s stock after purchasing an additional 2,773 shares during the quarter. UnitedHealth Group comprises 1.0% of Eos Management L.P.’s holdings, making the stock its 24th biggest position. Eos Management L.P.’s holdings in UnitedHealth Group were worth $2,514,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Beacon Financial Strategies CORP bought a new stake in UnitedHealth Group during the 4th quarter worth about $26,000. Foster Dykema Cabot & Partners LLC increased its stake in shares of UnitedHealth Group by 69.4% in the 3rd quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 34 shares during the last quarter. 1248 Management LLC bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at about $29,000. Holos Integrated Wealth LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at approximately $29,000. Finally, Hurley Capital LLC grew its position in shares of UnitedHealth Group by 81.6% in the 3rd quarter. Hurley Capital LLC now owns 89 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 40 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Up 2.2%

UNH opened at $353.51 on Thursday. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $438.85. The stock’s fifty day simple moving average is $290.76 and its 200 day simple moving average is $317.09. The company has a current ratio of 0.80, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. The stock has a market cap of $320.88 billion, a PE ratio of 26.70, a price-to-earnings-growth ratio of 1.53 and a beta of 0.40.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, beating analysts’ consensus estimates of $6.76 by $0.47. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The business had revenue of $111.65 billion for the quarter, compared to analysts’ expectations of $109.84 billion. During the same quarter in the prior year, the business earned $7.20 EPS. The firm’s revenue for the quarter was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, research analysts expect that UnitedHealth Group Incorporated will post 18.43 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were given a dividend of $2.21 per share. The ex-dividend date was Monday, March 9th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 67.02%.

Analyst Ratings Changes

Several equities analysts recently issued reports on UNH shares. Royal Bank Of Canada boosted their price objective on UnitedHealth Group from $361.00 to $400.00 and gave the company an “outperform” rating in a research report on Wednesday. Oppenheimer lifted their price objective on shares of UnitedHealth Group from $385.00 to $405.00 and gave the company an “outperform” rating in a report on Wednesday. Wells Fargo & Company boosted their price objective on shares of UnitedHealth Group from $370.00 to $397.00 and gave the stock an “overweight” rating in a research report on Wednesday. Raymond James Financial raised shares of UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 price objective on the stock in a research report on Wednesday, April 1st. Finally, Evercore raised shares of UnitedHealth Group to a “strong-buy” rating in a research report on Tuesday, January 6th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $377.68.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q1 beat and outlook raise — UNH reported stronger-than-expected Q1 results (EPS beat, $111.7B revenue) and raised 2026 adjusted EPS guidance, which investors interpreted as evidence the turnaround is underway. VIEW: UnitedHealth’s strong first quarter, forecast raise cheer Wall Street (Reuters)
• Positive Sentiment: Analyst upgrades and target hikes — Several firms (Argus, Oppenheimer, RBC, Wells Fargo, Morgan Stanley and others) raised ratings/targets after the quarter, signaling broader buy-side confidence and providing further upside signals for the stock. These Analysts Increase Their Forecasts On UnitedHealth After Upbeat Earnings (Benzinga)
• Positive Sentiment: AI and operational investments — Management announced meaningful AI spending (reported ~$1.5B) and expansion of Optum Real transaction processing, positioning Optum as a higher-throughput, margin-enhancing platform over time. UnitedHealth’s AI Is Rebuilding the Payment Layer of American Healthcare (PYMNTS)
• Positive Sentiment: Bullish options flow — Unusually large call buying was recorded (roughly 164k calls), suggesting short-term investor optimism or hedging ahead of follow-through. (No direct article link available)
• Neutral Sentiment: Rural health initiative — The company launched a broad rural-health program to serve underserved communities; positive for long-term growth/PR but unlikely to move near-term earnings materially. UnitedHealth Launches Broad Rural Health Initiative (InsiderMonkey)
• Neutral Sentiment: Industry/peer lift — Strong UNH results boosted sentiment across insurers (CVS, Humana, Centene), but sector moves may contain idiosyncratic risks tied to medical-cost trends and policy. UnitedHealth Sets Sights on AI, Climbs (Yahoo Finance)
• Negative Sentiment: Policy/program uncertainty — UnitedHealth flagged challenges with a Medicare obesity-drug pilot, creating uncertainty about participation and near-term costs related to new drug coverage programs. UnitedHealth flags challenges in Medicare obesity drug pilot (Reuters)
• Negative Sentiment: Residual analyst caution — A few firms still express caution (e.g., Robert W. Baird maintains an underperform view with a lower target), reflecting lingering concerns about execution and medical-cost volatility. Analyst note listing (Benzinga)

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.